Literature DB >> 9214597

Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.

S K Banerjee1, D K Sarkar, A P Weston, A De, D R Campbell.   

Abstract

Estrogens, which have been associated with several types of human and animal cancers, can induce tumor angiogenesis in the pituitary of Fischer 344 rats. The mechanistic details of tumor angiogenesis induction, during estrogen carcinogenesis, are still unknown. To elucidate the role of estrogen in the regulation of tumor angiogenesis in the pituitary of female rats, the density of blood vessels was analysed using factor VIII related antigen (FVIIIRAg) immunohistochemistry and the expression of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) was examined by Western blot and immunohistochemical analysis. The expression of VEGF receptor (VEGFR-2/Flk-1/KDR) was also examined by immunohistochemistry. The results demonstrated that 17beta-estradiol (E2) induces neovascularization, as well as the growth and enlargement of blood vessels after 7 days of exposure. The high tumor angiogenic potential was associated with an elevated VEGF/VPF protein expression in the E2 exposed pituitary of ovariectomized (OVEX) rats. VEGF/VPF and FVIIIRAg immunohistochemistry and endothelial specific lectin (UEA1) binding studies, indicate that the elevation of VEGF protein expression initially occurred in both blood vessels and non-endothelial cells. After 15 days of E2 exposure, VEGF/VPF protein expression, in the non-endothelial cell population, sharply declined and was restricted to the blood vessels. The function of non-endothelial-derived VEGF is not clear. Furthermore, immunohistochemical studies demonstrated that VEGFR-2 (flk-1/KDR), expression was elevated significantly in the endothelial cells of microblood vessels after 7 days of E2 exposure. These findings suggest that over expression of VEGF and its receptor (VEGFR-2) may play an important role in the initial step of the regulation of estrogen induced tumor angiogenesis in the rat pituitary.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9214597     DOI: 10.1093/carcin/18.6.1155

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  28 in total

Review 1.  Endocrine/paracrine control of pituitary cell proliferation and its involvement in pituitary tumorigenesis.

Authors:  M Pawlikowski
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Authors:  Matilde Lombardero; Sergio Vidal; Robert Hurta; Alba Román; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  Global analysis of gene expression in the estrogen induced pituitary tumor of the F344 rat.

Authors:  Douglas L Wendell; Adrian Platts; Susan Land
Journal:  J Steroid Biochem Mol Biol       Date:  2006-09-26       Impact factor: 4.292

Review 4.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

5.  Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas.

Authors:  Jorge Humberto Mukdsi; Ana Lucía De Paul; Silvina Gutiérrez; Félix Daniel Roth; Agustín Aoki; Alicia Inés Torres
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

6.  Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.

Authors:  S K Banerjee; A P Weston; M N Zoubine; D R Campbell; R Cherian
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

7.  Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors:  Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

8.  Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors.

Authors:  Abby J Sarkar; Kirti Chaturvedi; Cui Ping Chen; Dipak K Sarkar
Journal:  J Endocrinol       Date:  2007-02       Impact factor: 4.286

9.  2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells.

Authors:  Samarendra N Banerjee; Krishanu Sengupta; Snigdha Banerjee; Neela K Saxena; Sushanta K Banerjee
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

10.  Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat.

Authors:  Scott G Kurz; Kimberly K Hansen; Mac T McLaughlin; Vijay Shivaswamy; Beverly S Schaffer; Karen A Gould; Rodney D McComb; Jane L Meza; James D Shull
Journal:  Endocrinology       Date:  2008-04-17       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.